Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
MSP-00822 by Sathgen Biotech for Malignant Neoplasms: Likelihood of Approval
MSP-00822 is under clinical development by Sathgen Biotech and currently in Phase I for Malignant Neoplasms. According to GlobalData, Phase...
MSP-00822 by Sathgen Biotech for Metastatic Ovarian Cancer: Likelihood of Approval
MSP-00822 is under clinical development by Sathgen Biotech and currently in Phase I for Metastatic Ovarian Cancer. According to GlobalData,...
MSP-00822 by Sathgen Biotech for Metastatic Prostate Cancer: Likelihood of Approval
MSP-00822 is under clinical development by Sathgen Biotech and currently in Phase I for Metastatic Prostate Cancer. According to GlobalData,...
MSP-00822 by Sathgen Biotech for Triple-Negative Breast Cancer (TNBC): Likelihood of Approval
MSP-00822 is under clinical development by Sathgen Biotech and currently in Phase I for Triple-Negative Breast Cancer (TNBC). According to...
MSP-00822 by Sathgen Biotech for Head And Neck Squamous Cell Carcinoma (HNSC): Likelihood of Approval
MSP-00822 is under clinical development by Sathgen Biotech and currently in Phase I for Head And Neck Squamous Cell Carcinoma...